Annual Long Term Debt
$653.95 M
+$425.96 M+186.83%
December 31, 2021
Summary
- As of February 10, 2025, GBT annual long term debt is $653.95 million, with the most recent change of +$425.96 million (+186.83%) on December 31, 2021.
- During the last 3 years, GBT annual long term debt has risen by +$653.95 million (+100.00%).
Performance
GBT Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Debt
$652.27 M
-$893.00 K-0.14%
June 30, 2022
Summary
- As of February 10, 2025, GBT quarterly long term debt is $652.27 million, with the most recent change of -$893.00 thousand (-0.14%) on June 30, 2022.
- Over the past year, GBT quarterly long term debt has increased by +$426.56 million (+188.99%).
Performance
GBT Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
GBT Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +186.8% | +189.0% |
| 3 y3 years | +100.0% | +2612.3% |
| 5 y5 years | - | - |
GBT Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -0.3% | at low |
| 5 y | 5-year | at high | -77.7% | -0.3% | -77.6% |
| alltime | all time | at high | -100.0% | -0.3% | -100.0% |
Global Blood Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $652.27 M(-0.1%) |
| Mar 2022 | - | $653.16 M(-0.1%) |
| Dec 2021 | $653.95 M(+186.8%) | $653.95 M(+191.3%) |
| Sep 2021 | - | $224.50 M(-0.5%) |
| Jun 2021 | - | $225.71 M(-0.5%) |
| Mar 2021 | - | $226.91 M(-0.5%) |
| Dec 2020 | $227.99 M | $227.99 M(+47.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $154.32 M(-0.9%) |
| Jun 2020 | - | $155.68 M(+0.2%) |
| Mar 2020 | - | $155.33 M(+6.4%) |
| Dec 2019 | $145.92 M(>+9900.0%) | $145.92 M(+515.9%) |
| Sep 2019 | - | $23.69 M(-1.5%) |
| Jun 2019 | - | $24.05 M(-1.4%) |
| Mar 2019 | - | $24.40 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Global Blood Therapeutics annual long term debt?
- What is the all time high annual long term debt for Global Blood Therapeutics?
- What is Global Blood Therapeutics annual long term debt year-on-year change?
- What is Global Blood Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Global Blood Therapeutics?
- What is Global Blood Therapeutics quarterly long term debt year-on-year change?
What is Global Blood Therapeutics annual long term debt?
The current annual long term debt of GBT is $653.95 M
What is the all time high annual long term debt for Global Blood Therapeutics?
Global Blood Therapeutics all-time high annual long term debt is $653.95 M
What is Global Blood Therapeutics annual long term debt year-on-year change?
Over the past year, GBT annual long term debt has changed by +$425.96 M (+186.83%)
What is Global Blood Therapeutics quarterly long term debt?
The current quarterly long term debt of GBT is $652.27 M
What is the all time high quarterly long term debt for Global Blood Therapeutics?
Global Blood Therapeutics all-time high quarterly long term debt is $653.95 M
What is Global Blood Therapeutics quarterly long term debt year-on-year change?
Over the past year, GBT quarterly long term debt has changed by +$426.56 M (+188.99%)